Phase I Trial of Isatuximab Monotherapy in the Treatment of Refractory Multiple Myeloma
Blood Cancer Journal - United States
doi 10.1038/s41408-019-0198-4
Full Text
Open PDFAbstract
Available in full text
Date
March 29, 2019
Authors
Publisher
Springer Science and Business Media LLC